C4 Therapeutics Inc
NASDAQ:CCCC
C4 Therapeutics Inc
NASDAQ:CCCC
Price:
3.4
USD
-6.85%
Market Cap:
$375.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C4 Therapeutics Inc
NASDAQ:CCCC
|
US |
|
Bourse Direct SA
F:BD6
|
FR |
|
Conmed Corp
NYSE:CNMD
|
US |
|
C
|
Caesars Entertainment Inc
F:2ER
|
US |
|
C
|
Conmed Corp
XBER:EC8
|
US |
|
I
|
Innate Pharma SA
OTC:IPHYF
|
FR |
|
C
|
Charles River Laboratories International Inc
XMUN:RV6
|
US |
|
K
|
Koninklijke DSM NV
F:DSM2
|
NL |
|
C
|
Charles River Laboratories International Inc
F:RV6
|
US |
Multiples-Based Value
The Multiples-Based Value for C4 Therapeutics Inc (CCCC) under the Base Case is hidden
USD.
Compared with the current market price of 3.4 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CCCC Multiples-Based Value
LOCKED
